![Philippe Moyen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Philippe Moyen is currently the Chief Operating Officer at Maat Pharma SA since 2023.
Prior to this, he worked as the Vice President-Technical & Business Operations at PTC Therapeutics, Inc.
Postes actifs de Philippe Moyen
| Sociétés | Poste | Début |
|---|---|---|
| MAAT PHARMA | Directeur des opérations | 21/06/2023 |
Anciens postes connus de Philippe Moyen
| Sociétés | Poste | Fin |
|---|---|---|
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Maat Pharma SA
 Maat Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops and commercializes patient-microbiome symbiosis to improve survival outcomes in oncology | Health Technology |
